TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).
View Top Employees from Tetralogic PharmaceuticalsWebsite | http://www.tetralogicpharma.com |
Ticker | OTCPINK:TLOG |
Employees | 12 (12 on RocketReach) |
Founded | 2001 |
Phone | (610) 889-9900 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care, Pharmaceutical |
Looking for a particular Tetralogic Pharmaceuticals employee's phone or email?
Jennifer Burns is the Project Director of Tetralogic Pharmaceuticals.
12 people are employed at Tetralogic Pharmaceuticals.